{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-063025","form_type":"8-K","ticker":"CTKB","cik":"0001831915","company_name":"Cytek Biosciences, Inc.","filed_at":"2022-03-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.656819+00:00","generated_at":"2026-06-27T02:34:31.175691+00:00","sec_items":["5.02"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Cytek sets 2022 executive comp: salaries, bonuses, equity grants","bullets":["CEO Wenbin Jiang: 2022 base salary $545,000, target bonus 80% of base.","CTO Ming Yan: base $400,000, target bonus 50%; CFO Patrik Jeanmonod: base $385,000, target 50%.","Equity grants: CEO 163,158 options + 108,137 RSUs; CTO 47,841 options + 31,708 RSUs; CFO 42,310 options + 28,042 RSUs.","Options exercise price $13.64, vesting over 4 years; RSUs vest quarterly over 4 years.","2021 cash bonuses: CEO $163,687, CTO $134,451, CFO $106,492."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-063025","json":"https://secwatch.observer/filing/0001193125-22-063025.json","markdown":"https://secwatch.observer/filing/0001193125-22-063025.md","text":"https://secwatch.observer/filing/0001193125-22-063025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831915/000119312522063025/0001193125-22-063025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831915/000119312522063025/d214612d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T02:34:31.175691+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}